Bruntwood SciTech, the UK’s leading specialist property provider, founded by Legal & General and Bruntwood in 2018 to support the growth of the life science and tech sectors, has secured £500 million of additional investment and welcomed the UK’s largest local authority pension fund, Greater Manchester Pension Fund (GMPF), to the partnership. GMPF is the first local government pension scheme to make a direct and active investment into a UK-wide science, tech and innovation specialist property platform.
News
Cambridge, UK, 13 October 2023, Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, congratulates its Chief Scientific Officer (CSO), David Rees PhD, FMedSci, FRSC on being honoured by the American Chemical Society (ACS) Heroes of Chemistry.
Phil Melia and R&D expert, Max Stanyard, delve into how recent R&D changes impact UK life sciences businesses.
• The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry leads on a second neurological disease target
In the world of life science logistics, precision and reliability are paramount. John Roach, a Life Science Logistics Technician at Biocair with over 15 years of experience, shares his insights into this critical profession.
Howard Group strengthens team with appointment of Thomas Bewes as Asset Manager Surveyor joins Cambridge-based property investor and developer
Cambridge, 05 October 2022: Property investment and development company Howard Group is delighted to announce the appointment of Thomas Bewes MRICS as Asset Manager.
In June this year Sycamore House in Stevenage was the recipient of the Midlands and Central England region award within this category culminating in the national awards ceremony in London on the 3rd October.
Optimizing Smooth Muscle Cell Cryopreservation for Cardiovascular Research
AMSBIO, in collaboration with the University of Strathclyde (UK), announce the release of a poster that describes a comprehensive assessment of the effects of three different cryopreservation reagents (CELLBANKER® 1, CELLBANKER® 2 and commonly used 10% DMSO) on the viability and proliferative capacity of vascular smooth muscle cells (vSMCs)
Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization